4Filing Date: May 18, 2026

Solventum

Statement of Changes in Beneficial Ownership

View SEC Filing
ACC: 0001110753-26-000006
Total Value$0
Trades1
Insiders1

Transaction Details

COX CARRIE SMITH
Director·Direct
Grant · Acquire
Restricted Stock UnitsDerivative
Shares+4.85K
Price$0.00
Total Value$0
Shares Owned After4.85K
Transaction DateMay 15, 2026
Footnotes ▸

Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement. | The RSUs shall fully vest on May 15, 2027, subject to continued service through the vesting date. | The RSUs shall fully vest on May 15, 2027, subject to continued service through the vesting date.

Post-Transaction Holdings

COX CARRIE SMITH · Director
SecuritySharesChange
Restricted Stock Units4.85K+4.85K
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-05-15 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: Solventum Corp (SOLV) CIK: 0001964738 --- Reporting Owner --- Name: COX CARRIE SMITH CIK: 0001110753 Role: Director --- Derivative Transactions --- [Transaction #1] Security: Restricted Stock Units Date: 2026-05-15 | Code: A (Grant or award) Shares: +4,848 | Price: $0.00 Shares Owned After: 4,848 | Ownership: D (Direct) Footnotes: [F1] Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement. [F2] The RSUs shall fully vest on May 15, 2027, subject to continued service through the vesting date. [F2] The RSUs shall fully vest on May 15, 2027, subject to continued service through the vesting date. --- Footnotes (Complete Index) --- F1: Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement. F2: The RSUs shall fully vest on May 15, 2027, subject to continued service through the vesting date. --- Signature --- /s/ /s/Megan Bombick, attorney-in-fact for Carrie S. Cox (2026-05-18)

keid analysis is for reference only and does not constitute investment advice.